Form 4: Carlyle Group Sells QuidelOrtho Corp Shares Under 10b5-1 Plan

The Carlyle Group executed multiple sales of QuidelOrtho Corp shares on July 30 and 31, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Summary

• The Carlyle Group, a significant shareholder of QuidelOrtho Corp (QDEL), has reported the sale of shares on July 30 and 31, 2024.
• The sales were executed under a pre-arranged Rule 10b5-1 trading plan adopted on May 12, 2024.
• On July 30, 2024, Carlyle sold 2,205 shares at a weighted average price of $38.9331, 140,207 shares at a weighted average price of $39.7411, and 8,178 shares at a weighted average price of $40.0173.
• On July 31, 2024, Carlyle sold 45,395 shares at a weighted average price of $38.674 and 119,482 shares at a weighted average price of $39.2708.
• Following these transactions, Carlyle's indirect beneficial ownership of QuidelOrtho Corp shares decreased from 9,442,010 to 9,128,748.
• The shares are held of record by Carlyle Partners VI Cayman Holdings, L.P.
• Several entities within the Carlyle Group structure may be deemed to share beneficial ownership, but each disclaims such ownership.

Sentiment

Score: 5

Explanation: Neutral sentiment as it reports transactions without expressing positive or negative views on the company's prospects.

Risks

• Continued sales by Carlyle Group could exert downward pressure on QuidelOrtho Corp's stock price.

Industry Context

Share sales by major holders are common and can be part of portfolio management strategies. The use of a 10b5-1 plan suggests the sales were pre-planned and not based on recent market information.

Stakeholder Impact

• Shareholders may react to the news of Carlyle Group's share sales, potentially impacting the stock price.

Key Dates